Sizopin 25 mg Sun Pharmaceuticals Industries
| Features | |
| Active substance | Clozapine |
| Also known as | Clozaril |
| Blood pressure | Can cause orthostatic hypotension |
| Chemical name | 8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine |
| Dosage (medical) | Typically 300-450 mg/day, split into two or three doses |
| Dosage (sports) | Not applicable |
| Effects | Reduction in psychotic symptoms and mood stabilization |
| Formula | C18H19ClN4 |
| Half-life | Approximately 12 hours |
| Hepatotoxicity | Rare, but potential risk present |
| Lab Test | Regular monitoring of blood counts due to risk of agranulocytosis |
| Main action | Acts as an antagonist on various neurotransmitter receptors in the brain, including serotonin and dopamine receptors |
| Side effects | Agranulocytosis, seizures, myocarditis, orthostatic hypotension, anticholinergic side effects, weight gain |
| Storage conditions | Store at room temperature, 20В°C to 25В°C (68В°F to 77В°F) |
| Strength | 25mg |
| Substance class | Atypical antipsychotic |
| Trade name | Clozaril, Leponex, others |
| Use in sports | None |
| Water Retention | Minimal |
| Manufacturer | Sun Pharma Laboratories Ltd. |
| Packing | 10 tabs/blister |